KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 78 filers reported holding KEZAR LIFE SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $71,971 | +15.8% | 29,376 | +48.0% | 0.00% | – |
| Q1 2023 | $62,140 | -55.5% | 19,853 | 0.0% | 0.00% | – |
| Q4 2022 | $139,765 | -18.2% | 19,853 | 0.0% | 0.00% | – |
| Q3 2022 | $170,934 | +18.7% | 19,853 | +14.2% | 0.00% | – |
| Q2 2022 | $144,000 | -35.7% | 17,380 | +29.1% | 0.00% | – |
| Q1 2022 | $224,000 | -0.4% | 13,459 | 0.0% | 0.00% | – |
| Q4 2021 | $225,000 | +73.1% | 13,459 | -10.4% | 0.00% | – |
| Q3 2021 | $130,000 | +58.5% | 15,024 | 0.0% | 0.00% | – |
| Q2 2021 | $82,000 | -7.9% | 15,024 | +0.2% | 0.00% | – |
| Q1 2021 | $89,000 | +14.1% | 14,999 | 0.0% | 0.00% | – |
| Q4 2020 | $78,000 | +52.9% | 14,999 | +42.2% | 0.00% | – |
| Q3 2020 | $51,000 | -7.3% | 10,546 | 0.0% | 0.00% | – |
| Q2 2020 | $55,000 | -11.3% | 10,546 | -25.9% | 0.00% | – |
| Q1 2020 | $62,000 | +24.0% | 14,225 | +15.1% | 0.00% | – |
| Q4 2019 | $50,000 | – | 12,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |